5 Value Stocks In The Basic Materials Sector

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

What is a Value Stock?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga Insights has compiled a list of value stocks in the basic materials sector that may be worth watching:

  1. Huntsman (NYSE:HUN) – P/E: 5.3
  2. Nucor (NYSE:NUE) – P/E: 3.91
  3. Dow (NYSE:DOW) – P/E: 5.33
  4. Mosaic (NYSE:MOS) – P/E: 6.19
  5. Equinox Gold (AMEX:EQX) – P/E: 2.65

Huntsman’s earnings per share for Q1 sits at $1.19, whereas in Q4, they were at 0.95. The company’s most recent dividend yield sits at 2.39%, which has increased by 0.08% from 2.31% last quarter.

This quarter, Nucor experienced a decrease in earnings per share, which was $7.97 in Q4 and is now $7.67. Most recently, the company reported a dividend yield of 1.54%, which has decreased by 0.09% from last quarter’s yield of 1.63%.

Most recently, Dow reported earnings per share at $2.34, whereas in Q4 earnings per share sat at $2.15. Most recently, the company reported a dividend yield of 4.43%, which has decreased by 0.09% from last quarter’s yield of 4.52%.

This quarter, Mosaic experienced an increase in earnings per share, which was $1.95 in Q4 and is now $2.41. Most recently, the company reported a dividend yield of 0.98%, which has decreased by 0.25% from last quarter’s yield of 1.23%.

Equinox Gold’s earnings per share for Q1 sits at $-0.08, whereas in Q4, they were at 0.25.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Total
0
Shares
Related Posts
Read More

Sangamo Therapeutics Announced Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Nine Patients

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) today announced updated preliminary results from the Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry disease.

SGMO

Read More

Silicon Wars: Samsung Unveils Next-Gen AI Chips to Challenge TSMC’s Dominance

Samsung Electronics Co Ltd (OTC ) showcased its cutting-edge foundry technologies and AI-driven strategic vision at the Samsung Foundry Forum in San Jose, revealing new process nodes, SF2Z and SF4U, aimed at boosting AI chip production. These innovations underscore Samsung's commitment to leading the AI semiconductor revolution, aiming to challenge the market dominance of Taiwan Semiconductor Manufacturing Co.

ARM